320 related articles for article (PubMed ID: 17148673)
1. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
Crocker SJ; Whitmire JK; Frausto RF; Chertboonmuang P; Soloway PD; Whitton JL; Campbell IL
Am J Pathol; 2006 Dec; 169(6):2104-16. PubMed ID: 17148673
[TBL] [Abstract][Full Text] [Related]
2. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
3. Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice.
Thorne M; Moore CS; Robertson GS
J Neuroimmunol; 2009 Jun; 211(1-2):92-100. PubMed ID: 19428125
[TBL] [Abstract][Full Text] [Related]
4. The FcRgamma chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE.
Breij EC; Heijnen P; Vloet R; Saito T; van de Winkel JG; Dijkstra CD; Amor S; Verbeek S
J Neuropathol Exp Neurol; 2005 Apr; 64(4):304-11. PubMed ID: 15835266
[TBL] [Abstract][Full Text] [Related]
5. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
Juedes AE; Ruddle NH
J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
7. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
[TBL] [Abstract][Full Text] [Related]
8. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
[TBL] [Abstract][Full Text] [Related]
9. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the direct injury effector of oligodendroglia cells or myelin sheath in an experimental allergic encephalomyelitis model induced by the MOG35-55 peptide.
Zhou X; Li X; Feng M; Zhang Q; Yang Z
Mol Med Rep; 2015 Nov; 12(5):7425-32. PubMed ID: 26459920
[TBL] [Abstract][Full Text] [Related]
11. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
13. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Buhler LA; Samara R; Guzman E; Wilson CL; Krizanac-Bengez L; Janigro D; Ethell DW
BMC Neurosci; 2009 Mar; 10():17. PubMed ID: 19267908
[TBL] [Abstract][Full Text] [Related]
15. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
17. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
Eugster HP; Frei K; Kopf M; Lassmann H; Fontana A
Eur J Immunol; 1998 Jul; 28(7):2178-87. PubMed ID: 9692887
[TBL] [Abstract][Full Text] [Related]
18. The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice.
Heneka MT; Sharp A; Murphy P; Lyons JA; Dumitrescu L; Feinstein DL
J Neurochem; 2001 Apr; 77(2):568-79. PubMed ID: 11299319
[TBL] [Abstract][Full Text] [Related]
19. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
[TBL] [Abstract][Full Text] [Related]
20. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
Salama AD; Chitnis T; Imitola J; Ansari MJ; Akiba H; Tushima F; Azuma M; Yagita H; Sayegh MH; Khoury SJ
J Exp Med; 2003 Jul; 198(1):71-8. PubMed ID: 12847138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
